Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584688 · ClinicalTrials.gov registry record · Phase 2
A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study
A Phase 2 study, sponsored by University of South Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00584688 is a Phase 2 study that was terminated before completion, run by University of South Florida. The registered enrollment target is 24 participants.
The verdict
NCT00584688, a Phase 2 study, was terminated before completion, sponsored by University of South Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
Research studies raise the possibility that medications such as quetiapine may improve mood or reduce obsessions in people with anorexia nervosa and may even help to normalize appetite. The medication quetiapine also known as seroquel works by activating certain systems in the brain, such as ones known as dopamine and serotonin chemical systems in the brain.
Interventions
- DRUG quetiapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584688
The ClinicalTrials.gov registry entry for NCT00584688 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which quetiapine is the first listed.
NCT00584688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584688 about?
NCT00584688 is a clinical study titled "A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study". Research studies raise the possibility that medications such as quetiapine may improve mood or reduce obsessions in people with anorexia nervosa and may even help to normalize appetite. The medication quetiapine also known as seroquel works by activating certain systems in the brain, such as ones kn...
What is the current status of trial NCT00584688?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2007-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00584688?
The interventions under investigation include: quetiapine (DRUG).
Who is sponsoring clinical trial NCT00584688?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.